D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.68% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PUT
Li Auto
LI
$13.8B
| $1.05M | ﹤0.01% |
30,000
-251,600
| -89% | -$7.08M |
|
|
ITOS
2927
DELISTED
iTeos Therapeutics
ITOS
| $1.05M | ﹤0.01% |
79,482
+6,816
| +9% | +$97.2K |
|
|
KALV
2928
DELISTED
KalVista Pharmaceuticals
KALV
| $1.05M | ﹤0.01% |
116,862
+71,198
| +156% | +$656K |
|
|
PWSC
2929
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.05M | ﹤0.01% |
54,938
-465,117
| -89% | -$8.89M |
|
2930
Vital Farms
VITL
$592M
| $1.05M | ﹤0.01% |
87,557
+42,232
| +93% | +$590K |
|
2931
CALL
YPF
YPF
$19.5B
| $1.05M | ﹤0.01% |
70,500
-52,500
| -43% | -$637K |
|
2932
Wintrust Financial
WTFC
$10.9B
| $1.05M | ﹤0.01% |
14,408
-79,278
| -85% | -$5.41M |
|
|
OPI
2933
DELISTED
Office Properties Income Trust
OPI
| $1.05M | ﹤0.01% |
+135,745
| New | +$1.03M |
|
2934
Crescent Energy
CRGY
$3.44B
| $1.04M | ﹤0.01% |
100,086
+24,709
| +33% | +$265K |
|
|
EOCW
2935
DELISTED
Elliott Opportunity II Corp.
EOCW
| $1.04M | ﹤0.01% |
100,399
| – | – |
|
2936
Watsco Inc
WSO
$15.1B
| $1.04M | ﹤0.01% |
2,717
-28,834
| -91% | -$9.78M |
|
2937
ICICI Bank
IBN
$109B
| $1.03M | ﹤0.01% |
44,783
-261,171
| -85% | -$5.91M |
|
2938
PUT
Yeti Holdings
YETI
$3.93B
| $1.03M | ﹤0.01% |
26,600
-67,800
| -72% | -$2.63M |
|
|
SII
2939
Sprott
SII
$2.73B
| $1.03M | ﹤0.01% |
31,800
-1,500
| -5% | -$51.8K |
|
2940
Prudential
PUK
$36.1B
| $1.03M | ﹤0.01% |
+36,317
| New | +$1.04M |
|
2941
Tredegar Corp
TG
$263M
| $1.03M | ﹤0.01% |
+154,100
| New | +$1.22M |
|
2942
Stanley Black & Decker
SWK
$14.6B
| $1.03M | ﹤0.01% |
10,950
-381,717
| -97% | -$31.6M |
|
2943
Geron
GERN
$930M
| $1.03M | ﹤0.01% |
319,611
-1,324,777
| -81% | -$3.77M |
|
2944
CALL
MarineMax
HZO
$782M
| $1.02M | ﹤0.01% |
30,000
| – | – |
|
|
2945
PUT
MarineMax
HZO
$782M
| $1.02M | ﹤0.01% |
30,000
| – | – |
|
|
ALCYU
2946
DELISTED
Alchemy Investments Acquisition Corp 1 Units
ALCYU
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
2947
PUT
Tandem Diabetes Care
TNDM
$1.22B
| $1.02M | ﹤0.01% |
+41,700
| New | +$1.34M |
|
2948
Saic
SAIC
$5.14B
| $1.02M | ﹤0.01% |
+9,093
| New | +$944K |
|
|
BUJAU
2949
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Unit
BUJAU
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
2950
ESAB
ESAB
$5.54B
| $1.02M | ﹤0.01% |
15,295
-2,277
| -13% | -$138K |
|
Similar funds
D.E. Shaw & Co's Q2 2023 Portfolio in Review
As of Q2 2023, D.E. Shaw & Co held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Oracle worth $217M.
- D.E. Shaw & Co's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- D.E. Shaw & Co added most to NVIDIA in Q2 2023, an estimated $997M increase.
- D.E. Shaw & Co's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- D.E. Shaw & Co fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- D.E. Shaw & Co opened 467 new positions and closed 639 in Q2 2023.
- D.E. Shaw & Co's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.